METHODS: A GWAS was conducted in Japanese participants, involving 940 cases and 1634 controls, followed by a cross-ancestry meta-analysis of Japanese and European GWAS (total of 3760 cases and 11 635 controls). The novel loci were characterized by fine-mapping, gene expression, and splicing quantitative trait associations in the human heart.
RESULTS: The Japanese-specific GWAS identified one novel locus near ZSCAN20 (P = 1.0 × 10-8), and the cross-ancestry meta-analysis identified 17 association signals, including six novel loci. The effect directions of the 17 lead variants were consistent (94.1%; P for sign test = 2.7 × 10-4), and their allelic effects were highly correlated across ancestries (Pearson\'s R = .91; P = 2.9 × 10-7). The genetic risk score derived from the BrS GWAS of European ancestry was significantly associated with the risk of BrS in the Japanese population [odds ratio 2.12 (95% confidence interval 1.94-2.31); P = 1.2 × 10-61], suggesting a shared genetic architecture across ancestries. Functional characterization revealed that a lead variant in CAMK2D promotes alternative splicing, resulting in an isoform switch of calmodulin kinase II-δ, favouring a pro-inflammatory/pro-death pathway.
CONCLUSIONS: This study demonstrates novel susceptibility loci implicating potentially novel pathogenesis underlying BrS. Despite differences in clinical expressivity and epidemiology, the polygenic architecture of BrS was substantially shared across ancestries.
方法:在日本参与者中进行了GWAS,涉及940例和1634例控制,随后是日本和欧洲GWAS的交叉血统荟萃分析(总共3760例和11635例对照).新基因座的特征在于精细定位,基因表达,和剪接人类心脏中的数量性状关联。
结果:日本特异性GWAS在ZSCAN20附近发现了一个新基因座(P=1.0×10-8),交叉祖先荟萃分析确定了17个关联信号,包括六个新颖的基因座。17个导联变体的作用方向一致(94.1%;符号检验P=2.7×10-4),它们的等位基因效应在不同祖先之间高度相关(皮尔森的R=.91;P=2.9×10-7)。来自欧洲血统的BrSGWAS的遗传风险评分与日本人群的BrS风险显着相关[优势比2.12(95%置信区间1.94-2.31);P=1.2×10-61],暗示了祖先之间的共同遗传结构。功能表征显示,CAMK2D中的前导变体促进选择性剪接,导致钙调蛋白激酶II-δ的同工型开关,有利于促炎/促死亡途径。
结论:本研究表明新的易感基因位点与潜在的新的发病机制有关。尽管在临床表达和流行病学方面存在差异,BrS的多基因结构在祖先之间基本上共享。